Recent Insider Trading and Institutional Activity in $NTRA

On February 26, 2025, Jonathan Sheena, a director at $NTRA, sold 744 shares of the company for an estimated $119,673, according to a recent SEC filing. This sale represented about 1.7% of his holdings, leaving him with 43,674 shares of this class of Stock.

Overview of $NTRA Insider Trading

In the last six months, insiders at $NTRA have engaged in trading activities 178 times, all of which were sales with no reported stock purchases.

Here is a detailed account of key insider trades involving $NTRA Stock within that period:

• MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN): 0 purchases, 13 sales; 170,003 shares sold for approximately $28,179,841.
• STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT): 0 purchases, 21 sales; 113,075 shares sold for approximately $17,937,704.
• ROELOF BOTHA: 0 purchases, 5 sales; 87,473 shares sold for approximately $14,793,563.
• MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER): 0 purchases, 24 sales; 85,958 shares sold for approximately $14,425,269.
• JONATHAN SHEENA: 0 purchases, 67 sales; 88,988 shares sold for approximately $13,031,404.
• SOLOMON MOSHKEVICH (PRESIDENT, CLINICAL DIAGNOSTICS): 0 purchases, 13 sales; 40,726 shares sold for approximately $6,658,479.
• DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER): 0 purchases, 9 sales; 34,908 shares sold for approximately $5,741,526.
• ROY D. BAYNES: 0 purchases, 6 sales; 37,230 shares sold for approximately $5,439,564.
• JOHN FESKO (PRESIDENT, CHIEF BUSINESS OFFICER): 0 purchases, 11 sales; 28,060 shares sold for approximately $4,570,004.
• GAIL BOXER MARCUS: 0 purchases, 7 sales; 11,894 shares sold for approximately $1,899,602.
• ROWAN E CHAPMAN: 0 purchases, 2 sales; 4,381 shares sold for approximately $634,563.

For further insights into insider transactions, visit Quiver Quantitative’s insider trading dashboard.

Institutional Investor Activity in $NTRA

In the most recent quarter, 294 institutional investors added shares of $NTRA Stock to their portfolios, while 277 reduced their holdings.

Here are some of the significant transactions among these institutional investors:

• PRICE T ROWE ASSOCIATES INC /MD/: Added 3,871,862 shares (+134.9%) in Q4 2024, valued at approximately $612,915,754.
• JPMORGAN CHASE & CO: Added 2,069,396 shares (+44.7%) in Q4 2024, valued at approximately $327,585,386.
• MILLENNIUM MANAGEMENT LLC: Removed 1,021,889 shares (-72.0%) in Q4 2024, valued at approximately $161,765,028.
• FRED ALGER MANAGEMENT, LLC: Removed 994,184 shares (-24.8%) in Q4 2024, valued at approximately $157,379,327.
• BLACKROCK, INC.: Added 947,457 shares (+11.5%) in Q4 2024, valued at approximately $149,982,443.
• ALLIANCEBERNSTEIN L.P.: Removed 893,203 shares (-53.8%) in Q4 2024, valued at approximately $141,394,034.
• GOLDMAN SACHS GROUP INC: Added 887,710 shares (+110.0%) in Q4 2024, valued at approximately $140,524,493.

To monitor hedge funds’ Stock portfolios, please refer to Quiver Quantitative’s institutional holdings dashboard.

Congressional Trading Activity in $NTRA

Members of Congress have completed one trade involving $NTRA Stock in the past six months; that trade was a purchase.

Here is a summary of the recent congressional trading activity of $NTRA Stock:

For additional tracking of congressional Stock trading, please see Quiver Quantitative’s congressional trading dashboard.

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.

This article was originally published on Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.